-
Je něco špatně v tomto záznamu ?
Endoscopic treatment of malignant gastric and duodenal strictures: a prospective, multicenter study
A. Tringali, P. Didden, A. Repici, M. Spaander, MJ. Bourke, SJ. Williams, J. Spicak, P. Drastich, M. Mutignani, V. Perri, A. Roy, K. Johnston, G. Costamagna,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie, práce podpořená grantem
- MeSH
- časové faktory MeSH
- dospělí MeSH
- gastrointestinální endoskopie škodlivé účinky MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory trávicího systému komplikace MeSH
- obstrukce vyprazdňování žaludku etiologie terapie MeSH
- paliativní péče * MeSH
- prospektivní studie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- stenty * škodlivé účinky MeSH
- stupeň závažnosti nemoci MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- pozorovací studie MeSH
- práce podpořená grantem MeSH
BACKGROUND: Malignant gastric outlet obstruction is often treated by stent placement. OBJECTIVE: To investigate the outcomes of stent placement in the palliative treatment of malignant neoplasms. DESIGN: Prospective, observational, multicenter registry. SETTING: Six tertiary care centers in 5 countries. PATIENTS: A total of 108 adult patients with malignant gastric outlet obstruction. INTERVENTIONS: Placement of an uncovered, self-expandable, metal duodenal stent. MAIN OUTCOME MEASUREMENTS: The primary endpoint was stent patency at 14 days after stent implantation. Secondary endpoints included stent patency at 1, 2, 3, and 6 months, gastric outlet obstruction scoring system (GOOSS) scores at 14 days and 1, 2, 3, and 6 months after stent deployment, technical success, adverse events, and patient survival (ie, confirmed duration of the implant). RESULTS: Technical success was achieved in 99.1% of stent placements. Stent patency at 14 days was 94.6%. Kaplan-Meier estimates of stent patency were 92.9% at 1 month, 86.2% at 2 months, 81.9% at 3 months, and 63.4% at 6 months. At 14 days, GOOSS scores increased by a median of 1 point. The overall GI adverse event rate was 32.4%; however, the stent-related adverse event rate was 19.4%. The median implant duration was 47 days (range 0-195 days). LIMITATIONS: Observational study, no control group. CONCLUSIONS: Duodenal stent placement resulted in prompt relief of malignant gastric outlet obstruction and improved GOOSS scores. ( CLINICAL TRIAL REGISTRATION NUMBER: NCT00991614.).
Department of Gastroenterology and Hepatology Westmead Hospital Sydney New South Wales Australia
Department of Hepatogastroenterology IKEM Prague Czech Republic
Digestive Endoscopy Unit Catholic University Rome Italy
Digestive Endoscopy Unit IRCCS Istituto Clinico Humanitas Milan Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14074697
- 003
- CZ-PrNML
- 005
- 20141008121059.0
- 007
- ta
- 008
- 141006s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.gie.2013.06.032 $2 doi
- 035 __
- $a (PubMed)23932009
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Tringali, Andrea $u Digestive Endoscopy Unit, Catholic University, Rome, Italy.
- 245 10
- $a Endoscopic treatment of malignant gastric and duodenal strictures: a prospective, multicenter study / $c A. Tringali, P. Didden, A. Repici, M. Spaander, MJ. Bourke, SJ. Williams, J. Spicak, P. Drastich, M. Mutignani, V. Perri, A. Roy, K. Johnston, G. Costamagna,
- 520 9_
- $a BACKGROUND: Malignant gastric outlet obstruction is often treated by stent placement. OBJECTIVE: To investigate the outcomes of stent placement in the palliative treatment of malignant neoplasms. DESIGN: Prospective, observational, multicenter registry. SETTING: Six tertiary care centers in 5 countries. PATIENTS: A total of 108 adult patients with malignant gastric outlet obstruction. INTERVENTIONS: Placement of an uncovered, self-expandable, metal duodenal stent. MAIN OUTCOME MEASUREMENTS: The primary endpoint was stent patency at 14 days after stent implantation. Secondary endpoints included stent patency at 1, 2, 3, and 6 months, gastric outlet obstruction scoring system (GOOSS) scores at 14 days and 1, 2, 3, and 6 months after stent deployment, technical success, adverse events, and patient survival (ie, confirmed duration of the implant). RESULTS: Technical success was achieved in 99.1% of stent placements. Stent patency at 14 days was 94.6%. Kaplan-Meier estimates of stent patency were 92.9% at 1 month, 86.2% at 2 months, 81.9% at 3 months, and 63.4% at 6 months. At 14 days, GOOSS scores increased by a median of 1 point. The overall GI adverse event rate was 32.4%; however, the stent-related adverse event rate was 19.4%. The median implant duration was 47 days (range 0-195 days). LIMITATIONS: Observational study, no control group. CONCLUSIONS: Duodenal stent placement resulted in prompt relief of malignant gastric outlet obstruction and improved GOOSS scores. ( CLINICAL TRIAL REGISTRATION NUMBER: NCT00991614.).
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a nádory trávicího systému $x komplikace $7 D004067
- 650 _2
- $a gastrointestinální endoskopie $x škodlivé účinky $7 D016099
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a obstrukce vyprazdňování žaludku $x etiologie $x terapie $7 D017219
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a paliativní péče $7 D010166
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 12
- $a stenty $x škodlivé účinky $7 D015607
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a pozorovací studie $7 D064888
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Didden, Paul $u Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
- 700 1_
- $a Repici, Alessandro $u Digestive Endoscopy Unit, IRCCS Istituto Clinico Humanitas, Milan, Italy.
- 700 1_
- $a Spaander, Manon $u Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
- 700 1_
- $a Bourke, Michael J $u Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, New South Wales, Australia.
- 700 1_
- $a Williams, Stephen J $u Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, New South Wales, Australia.
- 700 1_
- $a Spicak, Julius $u Department of Hepatogastroenterology, IKEM, Prague, Czech Republic.
- 700 1_
- $a Drastich, Pavel $u Department of Hepatogastroenterology, IKEM, Prague, Czech Republic.
- 700 1_
- $a Mutignani, Massimiliano $u Digestive Endoscopy Unit, Catholic University, Rome, Italy.
- 700 1_
- $a Perri, Vincenzo $u Digestive Endoscopy Unit, Catholic University, Rome, Italy.
- 700 1_
- $a Roy, André $u Endoscopy Unit, Centre Hospitalier de l'Université de Montreal (CHUM), Hôpital Saint-Luc, Montréal Québec, Canada.
- 700 1_
- $a Johnston, Krystal $u MED Institute, Inc, West Lafayette, Indiana, USA.
- 700 1_
- $a Costamagna, Guido $u Digestive Endoscopy Unit, Catholic University, Rome, Italy.
- 773 0_
- $w MED00001881 $t Gastrointestinal endoscopy $x 1097-6779 $g Roč. 79, č. 1 (2014), s. 66-75
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23932009 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20141006 $b ABA008
- 991 __
- $a 20141008121447 $b ABA008
- 999 __
- $a ok $b bmc $g 1042580 $s 873609
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 79 $c 1 $d 66-75 $i 1097-6779 $m Gastrointestinal endoscopy $n Gastrointest Endosc $x MED00001881
- LZP __
- $a Pubmed-20141006
